Compound Detail
CHEMBL75753
XAMOTEROL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL75753 |
| Name | XAMOTEROL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | DXPOSRCHIDYWHW-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
3
Targets
8
Activities
2
Assay Types
9
PK Parameters
20
Publications
3
Known Names
1
Indications
1
Mechanisms
Molecular Properties
339.4
MW (Da)
-0.24
ALogP
6
HBA
4
HBD
103.3
PSA (Ų)
0.49
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Beta-1 adrenergic receptor partial agonist | PARTIAL AGONIST | Beta-1 adrenergic receptor | ✓ | ✓ |
Indications
Cardiovascular Diseases
ATC Classification
C01CX07
xamoterol
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY
Activity Summary
Kd 5 meas. best 7.75
EC50 3 meas. best 7.96
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-1 adrenergic receptor CHEMBL213 | EC50 | 7.96 | 7.96 | 11.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | Kd | 7.75 | 7.42 | 17.8 | 2 |
| Beta-2 adrenergic receptor CHEMBL210 | Kd | 6.18 | 5.97 | 660.7 | 2 |
| Beta-2 adrenergic receptor CHEMBL210 | EC50 | 6.15 | 6.15 | 708.0 | 1 |
| Beta-3 adrenergic receptor CHEMBL246 | Kd | 4.7 | 4.7 | 19952.6 | 1 |
| Beta-3 adrenergic receptor CHEMBL246 | EC50 | 4.0 | 4.0 | 100000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 3.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 3.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 3.0 | mL.min-1.kg-1 | Homo sapiens |
| F | 20.0 | % | Homo sapiens |
| Fu | 0.97 | - | Homo sapiens |
| Fu | 0.97 | - | Homo sapiens |
| MRT | 3.6 | hr | Homo sapiens |
| T1/2 | 7.7 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 6115058 | 10.1021/jm00135a015 | Canis familiaris | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 23614528 | 10.1021/jm400348g | Beta-2 adrenergic receptor | 4 |
| 23614528 | 10.1021/jm400348g | Beta-1 adrenergic receptor | 4 |
| 37468498 | 10.1038/s41467-023-40064-9 | Histamine H1 receptor | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 23614528 | 10.1021/jm400348g | Beta-3 adrenergic receptor | 3 |
| 23614528 | 10.1021/jm400348g | Unchecked | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 23984907 | 10.1021/jm400966v | Solute carrier family 22 member 1 | 2 |
| 23984907 | 10.1021/jm400966v | Solute carrier family 22 member 2 | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
| 3027335 | 10.1021/jm00385a001 | Beta-1 adrenergic receptor | 2 |
| 10891117 | 10.1021/jm0000564 | ADMET | 2 |
| 10891117 | 10.1021/jm0000564 | No relevant target | 2 |
Data from ChEMBL 36 via Core Engine